Introduction
The Ras guanine nucleotide exchange factor Sos is involved in the coupling of growth factor receptors to Ras-dependent mitogenic signaling pathways (Boguski and McCormick, 1993; Downward, 1994; Feig, 1994; Quilliam et al., 1995; Schlessinger, 1993) . A proposed mechanism suggests that recruitment of Sos to the plasma membrane via formation of a complex with Grb2 adapter proteins is responsible for activation of the mature, membrane-bound Ras proteins (Egan and Weinberg, 1993; McCormick, 1993; Pawson and Schlessinger, 1993 ). In this model, both the cytosolic and membrane-bound Sos forms are thought to exhibit similar nucleotide exchange activity, and no change of this exchange activity is supposed to occur as a consequence of relocation inside the cell. In support of this notion, constitutive or conditional membrane targeting of these exchange factors has been shown to potentiate Ras activation in transfected cells (Aronheim et al., 1994; Holsinger et al., 1995; Quilliam et al., 1994) . However, some reports suggest that, irrespective of subcellular location, the intrinsic guanine nucleotide exchange activity of Sos may be dierent before and after stimulation of surface tyrosine kinase receptors (Li et al., 1993a (Li et al., , 1995 (Li et al., , 1996 Rojas et al., 1999) . Sos consists of several de®ned domains, each involving a distinct function. For example, Ras activation is mediated by a central domain of Sos that is highly conserved among dierent Ras guanine nucleotide exchange factors (Boguski and McCormick, 1993) and its structure has been determined in complex with Ras (Boriack-Sjodin et al., 1998) . The SH3 domains of Grb2 bind to speci®c proline-rich sequences located in the C-terminal region of Sos (Chardin et al., 1993; Li et al., 1993b; RozakisAdcock et al., 1993) , that adopt a left-handed polyproline type II helix conformation Lim and Richards, 1994; Yu et al., 1994) , and some reports suggest that the C-terminal portion of Sos may exert negative regulation over the activity of the whole Sos1 protein (Byrne et al., 1996; Corbalan-Garcia et al., 1998; Karlovich et al., 1995; Kim et al., 1998; McCollam et al., 1995; Wang et al., 1995) . The proline-rich, C-terminal region of Sos contains a number of phosphorylation sites for MAPK and p90 RSK-2 (Cherniack et al., 1994; Corbalan-Garcia et al., 1996; Douville and Downward, 1997; Rozakis-Adcock et al., 1995) , and this phosphorylation may play a negative feedback role on the Ras pathway. Finally, the N-terminal region of Sos contains regions of homology to Dbl (DH) and pleckstrin (PH) domains implicated in phospholipid binding and Rac1 activation and their structures have also been determined (Koshiba et al., 1997; Soisson et al., 1998) .
Previously, we identi®ed two distinct human Sos1 isoforms (hSos1 Isf I and hSos1 Isf II) with dierent Grb2 binding anity (Rojas et al., 1996) . These isoforms dier only by the presence in hSos1 Isf II of a 15 amino acid stretch located close the ®rst prolinerich motif required for Grb2 binding. Some human tissues express only one isoform (fetal brain, and adult skeletal muscle, liver, lung and pancreas) whereas others express dierent proportions of both in fetal and adult stages. In vitro binding assays and yeast twohybrid analysis showed that hSos1 Isf II exhibits higher Grb2 anity than hSos1 Isf I (Rojas et al., 1996) .
Additionally, hSos1 Isf II is signi®cantly more eective than hSos1 Isf I to induce transforming phenotype of NIH3T3 cells when transfected alone or in conjunction with normal H-Ras (Rojas et al., 1999) . Furthermore, direct Ras guanine nucleotide exchange activity assays in cellular lysates showed that hSos1 Isf II transfectants consistently exhibited higher activity than hSos1 Isf I transfectants under unstimulated conditions (Rojas et al., 1999) .
We undertook the present study to explore the existence of a new SH3-minimal binding site into the 15 amino stretch speci®c of hSos1 Isf II, and to examine further its implication in the higher Grb2 binding anity of this isoform that hSos1 Isf I. Thus, we analysed in vitro and in vivo association of Grb2 with either hSos1 isoform C-terminal truncated mutants, containing only the SH3-minimal binding sites, and their functionality in the physiological activation of Ras.
Results
The C-terminal isoform-specific stretch of hSos1 contains a new putative SH3-minimal binding site
The C-terminal region of hSos1 contains four prolinerich Grb2-Binding Motifs (Grb2-BM) responsible for the interaction with Grb2 (PCCPPR) (Chardin et al., 1993; 1995; Cussac et al., 1994 Cussac et al., , 1999 Simon and Schreiber, 1995) . As shown in Figure 1a , in addition of these Grb2-BM, other putative domains containing the SH3-Minimal Binding Site (SH3-MBS) (CPXCP) (Sudol, 1998) could be identi®ed in the C-terminal region of hSos1. The human Sos1 isoforms (hSos1 Isf I and hSos1 Isf II) dier only by the presence in one of them (hSos1 Isf II) of a 15 amino acid stretch located in the C-terminal of hSos1 close to the ®rst Grb2-BM (Figure 1a ) (Rojas et al., 1996) . Furthermore, hSos1 Isf II exhibits much higher Grb2 binding anity than hSos1 Isf I (Rojas et al., 1996) . Since the 15 amino acid stretch speci®c of hSos1 Isf II contains one putative SH3-MBS (LPHGP) (Figure 1a) , we asked whether this additional domain could be responsible for the dierent Grb2 anity with either hSos1 isoform.
Therefore, we carried out pull-down assays to evaluate the Grb2 binding anity of dierent hSos1 Cterminal fragments. We expressed as glutathione Stransferase (GST)-fusion proteins (Guan and Dixon, 1991) either full-length C-terminal region of both isoforms (PRI, residues 1066 ± 1318 and PRII residues 1066 ± 1333, see Figure 1 ), or without the four Grb2-BM (CMRI, residues 1021 ± 1130; and CMRII, residues 1021 ± 1145, see Figure 1 ) (Chardin et al., 1993; Cussac et al., 1994; Li et al., 1993b) . Cytoplasmic extracts from human T24 bladder carcinoma cells were incubated with puri®ed GST-PRI, GST-PRII, GST-CMRI and GST-CMRII proteins coupled to glutathione sepharose Figure 1 Binding of cellular Grb2 to GST-CMRII and GST-CMRI fusion proteins in cell-free extracts. (a) C-terminal region of hSos1 showing the four Grb2 binding motifs (Grb2-BM), the minimal SH3 binding sites (SH3-MBS) and the 15 amino acid stretch (underlined) speci®c of hSos1-Isf II. The arrow highlighted the last amino acid of CMRI and CMRII proteins. (b) T-24 cell-free extracts were incubated with 10 mg of GST, GST-CMRI, GST-CMRII, GST-PRI and GST-PRII proteins coupled to glutathionesepharose beads. After washing, cellular proteins bound to the beads were run in SDS alongside the corresponding cell extract and immunoblotted against monoclonal Grb2 antibody. The top of the panel shows the scheme of domains of hSos1 and the C-terminal fragments of this protein used in the in vitro binding assays. DH, Dbl-homology. PH, Pleckstrin homology. REM, Ras exchanger motif. CDC25-H, CDC25 homology. PR, Proline-rich domain. Position of the 15 amino acid insert de®ning Isf II is indicated beads, and the proteins bound to the beads analysed by immunoblotting with antibodies to Grb2 (Figure 1b) , the same results were obtained with human M426 ®broblasts (data not shown). Whereas puri®ed GST alone did not bind any Grb2, similar amounts of Grb2 were bound to GST-PRI and PRII, and we also detected that GST-CMRI and CMRII bind Grb2. Control immunoblots with anti-GST antibodies showed similar signals in each case (data not shown). Normalizing the signal of Grb2 to that of GST in the immunoblots showed that GST-CMR II (containing the 15 amino acid stretch) proteins could bind up to threefold higher amounts of Grb2 than GST-CMRI and twofold lower than GST-PRII/PRI.
Yeast two hybrid analysis of interaction between Grb2 and C-terminal regions of hSos1 (Isf I and Isf II) without the four cannonical Grb2-binding motifs
We con®rmed the dierential Grb2 binding anity of CMRI and CMRII by evaluating their functional interaction with Grb2 in a yeast two hybrid system (Mendelsohn and Brent, 1994) (Figure 2) . A yeast host strain (EGY48), harboring both LacZ and Leu reporter genes under control of LexA, was cotransformed with a plasmid carrying Grb2 fused to the B42 activation domain and another plasmid containing either the hSos1 C-terminal truncated fragment described (CMRI or CMRII) or PRII (as positive control) fused to the LexA DNA-binding domain. The functional interaction between Grb2 and each construct was assessed as a function of detectable bgalactosidase activity and growth on medium without leucine (LEU + phenotype). Controls harboring the DHPH domain of hSos1 together with Grb2, or Grb2 or either hSos1 C-terminal fragment alone, did not elicit any b-galactosidase activity, (Figure 2a ) and did not grow well on leu 7 plates (Figure 2b ). Furthermore, transformants harboring both Grb2 and PRII yielded high levels of enzymatic activity, easily detected on yeast colonies (Figure 2a ) and displayed fast and high grown on medium without leucine. The interaction level between Grb2 and CMRII displayed by this twohybrid system was in accordance with the pull-down results, since b-galactosidase activity was clearly detectable, though somewhat weaker that Grb2+PRII colonies (Figure 2a) , and showed LEU + phenotype (Figure 2b ). In sharp contrast, transformants carrying Grb2 and CMRI elicit an almost undetectable bgalactosidase activity and did not grow well on leu 7 plates ( Figure 2 ). We used an on/o model to test the speci®city of these results. Thus, b-galactosidase activity and LEU + phenotype was detected only when the yeast colonies were patched on galactose-ranose selected medium (on state: expression of B42-Grb2) and was undetectable on glucose selected medium (o state: not expression of B42-Grb2) (Mendelsohn and Brent, 1994) . Again, these results con®rmed that CMRII is able to bind Grb2 and with higher anity than CMRI.
The putative SH3-minimal binding sites of CMRI and CMRII are responsible for the interaction with Grb2
Because our results suggested that the C-terminal region of either hSos1 isoform without the four cannonical Grb2-BM were able to bind Grb2, we asked if the putative SH3-MBS located in these regions (one in CMRI and two in CMRII) could be responsible for the binding with Grb2. We mutated all prolines of these putative SH3-MBS to alanines and we obtained three dierent GST constructs (Figure 3 ): GST-CMRI AA (with the two prolines of the unique putative SH3-MBS mutated to alanines), GST-CMRII AA (with the two prolines of the 15 amino acid stretch mutated to alanines) and GST-CMRII AA-AA (containing either putative SH3-MBS mutated the prolines to alanines). Again, cytoplasmic extracts from human T24 bladder carcinoma cells were incubated with puri®ed GST, GST-CMRII, GST-CMRI, GST-CMRII AA, GST-CMRII AA-AA and GST-CMRI AA proteins coupled to glutathione sepharose beads and the proteins bound to the beads analysed by immunoblotting with antibodies to Grb2 (Figure 3) , same results were obtained with human M426 ®broblasts (data not shown). Whereas puri®ed GST alone did not bind any Grb2, we detected that GST-CMRII and GST-CMRI bind Grb2 (although with higher anity for CMRII). However, we observed a drastic reduction of the Grb2 amount associated with GST-CMRII AA (consistently with the mutations into the 15 amino acid stretch) in comparison with the wild type GST-CMRII. As expected the mutants GST-CMRI AA (mutated in its unique putative SH3-MBS) and GST-CMRII AA-AA (mutated in either putative SH3-MBS) did not bind Grb2. Control immunoblots with anti-GST antibodies showed similar signals in each case (Figure 3) . Taken together, all these results demonstrated that the described putative SH3-MBS were responsible of the Grb2 binding acting as real binding-sites and supported that the isoformspeci®c stretch of hSos1 de®nes a new Grb2 bindingdomain.
The hSos1 isoforms lacking the four cannonical Grb2-binding motifs are able to originate in vivo stable complexes with Grb2
To extrapolate the results to an in vivo situation, we carried out truncations in the C-terminal of either hSos1 isoform. To this end, we obtained hSos1-CMRI and hSos1-CMRII constructs consisting of full-length hSos1 lacking the four Grb2-BM. Transient transfections of 293T cells with the epitope-tagged (HA) constructs of these truncated mutants or the wild type isoforms of hSos1, showed the overexpression to similar levels of all these proteins and with the predicted sizes ( Figure 4 ). Cellular lysates and antiGrb2 immunoprecipitates of those transfectants were further analysed by immunoblotting with anti-HA antibodies ( Figure 4 ). We consistently detected higher amounts of coimmunoprecipitated HA-hSos1 Isf II than HA-hSos1 Isf I. Interestingly, the immunoblot analyses with anti-HA demonstrated that both HAhSos1-CMRI and HA-hSos1-CMRII were in vivo associated with Grb2. Furthermore, the amounts of coimmunoprecipitated HA-hSos1-CMRII were higher than HA-hSos1-CMRI (and lower than hSos1 Isf I/Isf II) (Figure 4 ), in agreement with the higher capacity to bind Grb2 by the CMR II than CMR I fragments described in the above assays. The speci®city of this interaction was demonstrated by using the plasmid Interaction between Grb2 and hSos1 C-terminal fragments in a yeast two-hybrid system. A B42 activation domain fusion plasmid coding for B42-Grb2 (construct in pJG4-5) was cotransformed into yeast strain EGY48 (ura3, his3, trp1, with the plasmid pSH18-34 (LacZ reporter with LexA binding sites) and with LexA DNA binding domain fusion plasmids (constructs in pEG202) coding respectively for the LexA fused to the same CMRI, CMRII and PRII (positive control) fragments tested in Figure 1a and for the DHPH region of hSos1 (negative control). As others negative controls, plasmid pJG4-5 was cotransfected with pEG202-CMRI (CMRI+Vector), pEG202-CMRII (CMRII+Vector), pEG202-PRII (PRII+Vector) or pEG202 alone (Vector+Vector), and plasmid pEG202 was cotransformed with pJG4-5-Grb2 (Vector+Grb2). Four independent colonies from each cotransformation were analysed for b-galactosidase activity in color X-Gal plates assay (a) and for LEU + phenotype by patching these colonies in medium lacking leucine (b). The speci®city of the interactions was tested by dependence to galactoseranose (a and b) (data not shown) and all these data indicate that the truncated mutants hSos1-CMRI and hSos1 CMRII may originate in vivo stable complexes with Grb2.
C-terminal truncated mutants of the hSos1 isoforms (lacking the four cannonical Grb2-binding motifs) are functional in vivo and physiologically active
To go further into whether the hSos1 C-terminal truncated mutants were functionally active to catalyse the exchange of bound GDP for GTP on Ras, we investigate whether the overexpression of the above mutants was per se sucient to induce Ras activation. Thus, we decided to measure the level of Ras-GTP in transient transfectants overexpressing either hSos1 construct. We used a non-radioactive Ras-GTP detection assay by incubating the cell lysates with sepharose-GST-RBD (Ras Binding Domain of Raf-1) beads and immunoblotting with speci®c antibodies (Taylor and Shalloway, 1996) . Figure 5a shows representative results comparing the levels of Ras-GTP in transient cotransfected Cos 1 cells, expressing AU5-H-Ras wild type and HA-tagged constructs of either hSos1 isoform (full-length or truncated), under basal conditions. As controls, Cos 1 cells harboring AU5-H-Ras wild type alone (basal conditions or EGF stimulated) or AU5-H-Ras Val 12 were analysed in parallel. Analysis of GTP-bound Ras in cell lysates expressing either full-length or truncated mutants of hSos1 showed (in all cases) triggering of Ras activation, compared with the obtained in cells harboring AU5-H-Ras wild type alone under basal conditions ( Figure 5a ). The amounts of AU5-H-Ras-GTP ± normalized to AU5-H-Ras levels (Figure 5b ) ± in the cells harboring HA-hSos1 Isf I were slightly lower than those obtained by EGF stimulation in cells transfected with AU5-H-Ras wild type alone. In accordance with previously published data (Rojas et al., 1999) , the basal levels of AU5-H-Ras-GTP ( Figure  5b ) in cotransfectants overexpressing HA-hSos1 Isf II were higher than those measured in Isf I-expressing cells, but lower than those produced in cells harboring AU5-H-Ras Val 12 (Figure 5a ). Interestingly, in the same unstimulated conditions, both truncated mutants induced Ras-GTP levels twofold higher than full-length hSos1 Isf I and slightly higher than hSos1 Isf II ( Figure  5b) . A more adequate model to investigate the physiological behavior of the hSos1 truncated mutants is the analysis of endogenous Ras activation induced by the stimulation of receptor protein tyrosine kinases, such as the epidermal growth factor receptor (EGFR). Therefore, Cos 1 cells transiently transfected with the hSos1 constructs or vector alone were serum-starved for 18 h and then stimulated with EGF (Figure 5c ), and the endogenous Ras-GTP was detected by the previous non-radioactive method (Taylor and Shalloway, 1996) . Unlike the results under unstimulated conditions (Figure 5a,b) , cells overexpressing hSos1 (full-lengths or truncated mutants) showed a similar increase of Ras-GTP upon EGF stimulation (Figure 5c and normalizing data not shown). Taken together, these results indicate that both hSos1-CMRI and hSos1-CMRII may activate Ras as the same level Figure 3 The SH3-Minimal Binding Sites of CMRI and CMRII are responsible for the interaction with Grb2. T-24 cell-free extracts were incubated with 10 mg of GST, GST-CMRII, GST-CMRI, and the SH3-MBS mutants: GST-CMRII AA, GST-CMRII AA-AA and GST-CMRI AA, proteins coupled to glutathione-sepharose beads. After washing, cellular proteins bound to the beads were run in SDS alongside the corresponding cell extract and immunoblotted against monoclonal Grb2 antibody. As control, the ®lter was stripped and re-blotted against polyclonal GST antibody. The top shows the scheme of the C-terminal fragments mutants of hSos1 used in the in vitro binding assays SH3 binding site in the specific stretch of hSos1 Isf II N Zarich et al and physiological pattern as hSos1 full-length proteins upon EGF stimulation. A consequence of the Ras-GTP state is the activation of the Raf-MEK-MAPK pathway (Joneson and Bar-Sagi, 1997) . After threonine and tyrosine phosphorylation, the MAPK (ERK1 and ERK2) are translocated to the cell nucleus and they activate (by phosphorylation) several transcription factors (Elk1, Ets1-2, etc.). The mutated hSos1 proteins were studied for their ability to stimulate MAPK by using a reporter assay in NIH3T3 cells cotransfected with the above hSos1 constructs or H-Ras (wild type or Val 12), together with a chimerical Gal4-Elk1 transcription factor (containing the DNA binding domain of Gal4 and the activation domain of Elk1) and the reporter plasmid TATA-Gal4-Luc. Figure 5d shows the results obtained in a set of transient transfection experiments where we measured the induction of luciferase activity in starved conditions. Again, H-Ras Val 12 was signi®cantly potent to activate Gal4-Elk1, and the transcriptional activation induced by hSos1 (full-length or truncated) was, in all cases, higher than the corresponding H-Ras wild type alone and more potent with either hSos1 truncated mutants than the fulllength isoforms. These results con®rm that both hSos1-CMRI and hSos1-CMRII may activate the ERK pathway like hSos1 Isf I and hSos1 Isf II full-length proteins do, in accordance with previous Ras-GTP results.
Biological characterization of NIH3T3 cells transfected with the hSos1 isoforms C-terminal truncated mutants
To ascertain possible biological dierences between the wild type isoforms and the C-terminal truncated mutants of hSos1, we tested the ability of mammalian expression vectors driving expression of either isoform to induce formation of transformed foci after transfection into NIH3T3 cells. The dierence in transforming potency between the isoforms I and II and C-terminal truncated mutants was manifested in experiments where the hSos1 constructs were cotransfected with normal ras genes. To this end, NIH3T3 cells were cotransfected with the above hSos1 constructs and HRas wild type, and the transformed foci ( Figure 6 ) were detected as described previously (Rojas et al., 1996) . The overexpression of H-Ras wild type alone produced weak, but reproducible, transforming activity that was enhanced several fold when hSos1 constructs (full-length or truncated mutants) were included in the cotransfection experiments (Figure 6 ). The same hSos1 constructs, when they were overexpressed alone, induced a similar number of foci than H-Ras wild type alone (data not shown). As shown in Figure 6 , hSos1-Isf I constructs produced only a modest increase in focus formation over the number of foci produced by H-Ras wild type alone. In contrast, cotransfection of hSos1-Isf II with H-Ras wild type resulted consistently in a more than threefold increase over Figure 4 . The transfected cells were serum-starved for 18 h and then treated without (lanes 7) or with EGF (100 ng/ml, 10 min) (lane+). Ras-GTP was recovered from cell lysates by binding to immobilized GST containing the Ras-GTP binding domain of Raf (Taylor and Shalloway, 1996) and detected by immunoblotting with anti-AU5 monoclonal antibody (middle autoradiograma). The expression levels of the transfected AU5-H-Ras and HA-hSos1 constructs were detected by immunoblotting of the cell extracts with the corresponding anti-tag monoclonal antibody (upper and lower autoradiogramas). A shorter exposure of Ras-GTP (middle autoradiograma) corresponding to the constitutively activated H-Ras Val 12 (used as the positive control) was spliced into the ®gure. Results presented correspond to a representative experiment, and similar results were obtained in three additional, separate experiments. (b) Quantitation of Ras-GTP normalized (by GelWoks Analyses) to Ras levels corresponding to the experiments indicated in a. Histogram represents the average and standard deviation of four separate assays. (c) Cos 1 cells transfected, with the same pCEFL-KZ-HA-hSos1 constructs used in a or with the empty vector pCEFL-KZ-HA, were serum-starved for 18 h and then treated without (lanes7) or with EGF (100 ng/ml, 10 min) (lanes+). Ras-GTP was detected as a but using anti pan Ras antibody for the immunoblotting. The expression levels of the HA-hSos1 and the endogenous Ras were detected by immunoblotting of the cell extracts with the anti-HA and anti-pan Ras antibodies respectively (upper and lower autoradiogramas). Results presented correspond to a representative experiment, and similar results were obtained in three additional, separate experiments. (d) NIH3T3 cells were cotransfected with the plasmid pcDNAIII-Gal4-Elk-1 (Marinissen et al., 1999) encoding the Gal4-Elk1 fusion protein (containing the Gal4 DNA binding domain and the activation domain of Elk1), the plasmid pGal4-Luc (Marinissen et al., 1999) containing the Photinus luciferase gene controlled by six copies of a Gal4 responsive element and the plasmid pRL-TK containing the Renilla luciferase gene under control of the HSV-TK promoter region, together expression plasmids pCEFL-AU5 or pCEFL-HA containing the indicated H-Ras wt, HRas Val 12 and the hSos1 constructs described. Cells were serum-starved and assayed 24 h later for luciferase activity. The data represent Photinus luciferase activity normalized by the Renilla luciferase activity present in each cellular lysate, expressed as fold induction with respect to control cells and are the average and standard deviation of three separate assays performed in duplicate SH3 binding site in the specific stretch of hSos1 Isf II N Zarich et al the number of transformed foci produced by normal H-Ras alone ( Figure 6 ). Furthermore, either hSos1-CMR I or hSos1-CMR II cotransfected with H-Ras wild type were more active on the induction of focus formation than either hSos1 full-length isoform cotransfected with H-Ras wild type (Figure 6 ), and this dierence of foci was consistent with the above results of Ras and MAPK activation and with the published observations about the negative-regulatory eect of the carboxyl terminal region of Sos (CorbalanGarcia et al., 1998; Kim et al., 1998; McCollam et al., 1995; Rojas et al., 1999; Wang et al., 1995) . These results support that either hSos1-CMRI or hSos1-CMRII may display the same biological eect than the full-length hSos1 Isf I and hSos1 Isf II to synergize with H-Ras wild type on the induction of cell transforming phenotype.
The SH3-MBS of the 15 amino acid stretch is responsible for the physiological property differences between hSos1 isoforms
Previously, we found that hSos1 Isf II is more eective than hSos1 Isf I to induce activation of the Ras-Raf-MAPK pathway (Rojas et al., 1996 (Rojas et al., , 1999 . In this context, a critical question is whether the SH3-MBS into the stretch speci®c of isoform II, which increase the anity to Grb2, is also in vivo responsible for the dierent functionality of hSos1 Isf II versus hSos1 Isf I. To explore this possibility, we mutated the two prolines of the 15 amino acid stretch to alanines in the full-length hSos1 Isf II, obtaining the mutant hSos1 Isf II AA. We compared the capacity of hSos1-Isf I, hSos1 Isf II and hSos1 Isf II AA to activate MAPK using a Gal4-Elk1/TATA-Gal4-Luc reporter assay. Figure 7 shows the results obtained in a set of transient transfection experiments, where we measured the induction of luciferase activity in starved conditions. Again, hSos1 Isf II was more potent than hSos1 Isf I in inducing MAPK activation, whereas the mutant hSos1 Isf II AA showed the same level of luciferase activity as isoform I. These results provide a functional evidence of the importance of the speci®c isoform II SH3-MBS in the context of the full-length hSos1 Isf II molecule, and suggest that this motif is responsible for the physiological property dierences between hSos1 isoforms.
Discussion
We previously identi®ed the existence of two distinct human Sos1 isoforms (designated hSos1 Isf I and hSos1 Isf II) diering only by the presence in Isf II of a 15 amino acid stretch located close the ®rst proline-rich motif required for Grb2 binding. In vitro binding assays using GST-fusion proteins and yeast two-hybrid analysis showed that hSos1-Isf II exhibits signi®cantly higher Grb2 anity than hSos1 Isf I (Rojas et al., 1996) . In addition, we found that hSos1 Isf II is signi®cantly more eective than hSos1 Isf I to induce malignant transformation of rodent ®broblasts when transfected alone or in conjunction with H-Ras wild type, and direct Ras guanine nucleotide exchange activity assays in cellular lysates showed that hSos1 Isf II transfectants consistently exhibited about threefold higher activity than hSos1 Isf I transfectants under basal, unstimulated conditions (Rojas et al., 1999) . The increased Grb2 binding anity of hSos1 Isf II as compared to hSos1 Isf I was also consistent with computer predictions of the secondary structure of hSos1 protein, caused by the presence of the 15 amino acid stretch in its C-terminal proline-rich region (Rojas Figure 6 Focus formation assay in NIH3T3 cells cotransfected with H-Ras wt and hSos1 constructs. NIH3T3 cells were cotransfected with 1 mg of pCEFL-KZ-AU5-H-Ras wt and 1 mg of each pCEFL-KZ-HA-hSos1 constructs described in Figure 4 . After 14 days the dishes were stained with Giemsa to score the transformed foci. All plasmids DNAs produced similar numbers of marker-selectable colonies. The data are averages and standard deviation of three independent assays performed in duplicate Figure 7 Role of the SH3-MBS speci®c of hSos1 Isf II in the dierent capacity to activate ERK pathway by either hSos1 isoform. NIH3T3 cells were cotransfected with the plasmids pcDNAIII-Gal4-Elk-1, pGal4-Luc and pRL-TK (Figure 5d ), together with expression vector pCEFL-HA empty or containing the full-length hSos1 Isf I, hSos1 Isf II or hSos1 Isf II AA (two prolines of speci®c SH3-MBS mutated for alanines), respectively. Cells were serum-starved and assayed 24 h later for luciferase activity. The data represent Photinus luciferase activity normalized by the Renilla luciferase activity present in each cellular lysate, expressed as fold induction with respect to control cells and are the average and standard deviation of three separate assays performed in duplicate et al., 1996) . According to those predictions the 15 amino acid stretch could cause a very marked increase in overall surface accessibility of the neighboring ®rst Grb2-binding motif (Grb2-BM) (PPVPPR) required for optimal Grb2 SH3 binding (Chardin et al., 1993 (Chardin et al., , 1995 Cussac et al., 1994 Cussac et al., , 1999 Li et al., 1993b; Simon and Schreiber, 1995) . In conclusion, our ®rst hypothesis was than an increased accessibility to solvent, due to the 15 amino acid stretch, of this proline-rich region could contribute to the higher Grb2 binding ability displayed by hSos1 Isf II (Rojas et al., 1996) .
However, another possibility could be argued as an explanation of the Grb2 binding dierence, namely, a new SH3 binding site into the 15 amino acid stretch. The SH3 domains bind proline-rich motifs that adopt a left-handed polyproline type II helix conformation Lim and Richards, 1994; , and the C-terminal region of hSos1 contains four proline-rich Grb2-Binding Motifs (Grb2-BM), which have the core sequence: PCCPPR (Chardin et al., 1993 (Chardin et al., , 1995 Cussac et al., 1994 Cussac et al., , 1999 Simon and Schreiber, 1995) . Independently of these motifs, the general consensus sequence for SH3 domain ligands is CPXCP (Mayer and Eck, 1995; Ren et al., 1993; Sudol, 1998 ) that we denoted as SH3-Minimal Binding Site (SH3-MBS). Eight SH3-MBS are located in the Cterminal of hSos1 (positions 1021 ± 1333) ( Figure 1 ): two of them are positioned downstream of the Grb2-BS, four of them are included in the Grb2-BS, and the other two are located upstream of the four Grb2-BS. Speci®cally, one of these last two SH3-MBS is common to both hSos1 isoforms (LPRFP: positions 1024 ± 1028) and the other one is speci®c for hSos1 Isf II (LPHGP: ®ve last residues of the 15 amino acid stretch).
Here, we decided to analyse whether the SH3-MBS located into isoform II stretch could be relevant regarding the more eective binding of Grb2 to hSos1 Isf II than hSos1 Isf I. The results obtained by in vitro (pull-down assays) and yeast two hybrid experiments demonstrate that the proline-rich region of hSos1 Isf II without the four Grb2-BM is able to bind Grb2. This peptide contains the two upstream SH3-MBS denoted above. The same peptide of hSos1 Isf I (containing only one SH3-MBS) binds slightly Grb2 by pull-down assays, and it did not show positive results in yeast two hybrid experiments. In relation with this, some reports have indicated that the C-terminal region of hSos1 Isf I containing only the ®rst two Grb2-BM is negative to bind Grb2 by yeast two hybrid approach (Chardin et al., 1993; Rojas et al., 1996) , unlike the same region of hSos1 Isf II (Rojas et al., 1996) . Given that the unique dierence among these proline-rich peptides is the 15 amino acid stretch, the above and previous data provide support for the hypothesis about that the new SH3-MBS contained into the 15 amino acid stretch could be responsible for the higher Grb2 binding anity of hSos1 Isf II than hSos1 Isf I. In accordance with this, the results obtained by Grb2 pull-down assays with dierent mutants, originated by site-directed mutagenesis in which the proline of SH3-MBS were substituted for alanine, demonstrated that these putative SH3-MBS are real domains responsible for the Grb2 binding and that the isoform-speci®c stretch of hSos1 de®nes a new Grb2 binding-domain.
In vivo assays showed that either hSos1 isoform without the four Grb2-BM were able to originate stable complexes with Grb2 (although with more anity in the case of isoform II), and may activate the Ras-MAPK pathway. Speci®cally, this Ras and MAPK induced activation were higher, under basal conditions, and at same level and following same functional pattern upon EGF stimulation, that than of hSos1 full-length proteins (Egan and Weinberg, 1993; McCormick, 1993; Pawson and Schlessinger, 1993) . Obviously, we cannot discard that other domains of hSos1 (dierent of the C-terminal region) could be responsible for the stability of association with Grb2 (although it is very improbable), but the results of this report argue against the idea that the four Grb2-BM are strictly necessary for Grb2-hSos1 complexing and physiological activity (upon tyrosine kinase receptor stimulation) of hSos1 proteins (Chardin et al., 1993 (Chardin et al., , 1995 Li et al., 1993b; Rozakis-Adcock et al., 1992 . Moreover, the mutation of the prolines within the SH3-MBS speci®c of isoform II reduces the functionality of this protein to the levels of hSos1 Isf I in the Ras-Raf-MAPK activation, suggesting a role of that motif in the physiological property dierences between both isoforms. Furthermore, cotransfection experiments showed that either hSos1 isoform, without the four Grb2-BM, caused a higher increase in the number of foci produced by cotransfected normal Hras genes, than cotransfection of either hSos1 fulllength isoform with normal H-ras genes, in accordance with the results of Ras and MAPK activation under unstimulated conditions. These data are consistent with other reports suggesting that the C-terminal portion of Sos1 may exert negative regulation over the activity of the whole Sos1 protein (Aronheim et al., 1994; Byrne et al., 1996; Corbalan-Garcia et al., 1998; Kim et al., 1998; McCollam et al., 1995; Quilliam et al., 1995; Rojas et al., 1999; Wang et al., 1995) . The stoichiometry of the Grb2-Sos complex is not clearly de®ned and, though the relation 1 : 1 is possible, the existence in the C-terminal region of hSos1 of four Grb2-BM and four independent SH3-MBS suggests that several molecules of Grb2 may be associated with one molecule of hSos1. Our hypothesis is that the role of Grb2 is not only to recruit Sos to the plasma membrane, upon tyrosine kinase receptor stimulation, but also to control the nucleotide exchange activity of Sos. In agreement with this, the absence of the four Grb2-BM diminished the Grb2 binding capacity of hSos but increased the synergistic eect with normal H-Ras on the induction of transforming foci. In that regard, it is interesting to note that microinjection with bacterially expressed peptides fragments of the C-terminal region of hSos1 Isf II induce Xenopus oocyte maturation (by activation of the Ras pathway), suggesting that they do so by interacting with some of the intracellular target(s) of endogenous Sos in the oocyte (Rojas et al., 1999) . Furthermore, the proline-rich, C-terminal region of Sos contains a number of phosphorylation sites for MAPK and p90 RSK-2 (Cherniack et al., 1994; CorbalanGarcia et al., 1996; Douville and Downward, 1997; Rozakis-Adcock et al., 1995) , and this phosphorylation may play a negative feedback role on the Ras pathway. Obviously, several of these phosphorylation sites are absent in the C-terminal truncated mutants.
The existence of two functionally dierent hSos1 isoforms, with dierential expression patterns and SH3 binding site in the specific stretch of hSos1 Isf II N Zarich et al distribution in adult and fetal tissues (Rojas et al., 1996) , suggests ®nely modulated mechanisms controlling Ras activation in dierent tissues or at dierent stages of development. As an alternative scenario, it is possible that hSos1 isoforms with dierent Grb2 binding capacity could also regulate signal transduction uxes by disrupting the association of Grb2 with other proteins. In this respect, Grb2 SH3 domains has been shown to interact with a plethora of unrelated molecules besides Sos, including Rap-(C3G) exchange factors (Gotoh et al., 1995; Guerrero et al., 1998) , regulators of the Rac/Rho family (Vav) (Ye and Baltimore, 1994) , cytoskeletal proteins such as dynamin and synapsin I (McPherson et al., 1994; Pawson, 1995) as well as protein tyrosine phosphatases (den Hertog et al., 1994) . Since these proteins bind to the Grb2 SH3 domains, the presence of two hSos1 isoforms with dierent Grb2 binding capacity could dierentially modulate the separate pools of intracellular complexes containing Grb2. Furthermore, it has been recently identi®ed that the endocytic protein intersectin competes with the SH3 domains of Grb2 in binding to Sos1 (Tong et al., 2000) . Current studies exploring the mechanism(s) whereby the C-terminal region of hSos1 exerts a negative regulation on the activity of this protein, including the functional role of Grb2, as well as the modulation of other Grb2 complexes are expected to help de®ne the physiological responses mediated by the two hSos1 isoforms.
Materials and methods

Cell lines
NIH3T3 cells were maintained in Dulbecco's modi®ed Eagle's medium (DMEM: Life Technologies, Inc.) supplemented with 10% calf serum. Cos 1 and the human 293T (kidney keratinocyte), M426 (lung embryonic ®broblasts) and T24 (bladder carcinoma) cell lines were maintained in DMEM (Life Technologies, Inc.) supplemented with 10% fetal bovine serum.
DNA constructs
C-terminal coding regions of hSos1 Isf I (PRI, residues 1066 ± 1318) from pSP72-hSos1 Isf I and hSos1 Isf II (PRII, residues 1066 ± 1333) from pGEM-hSos1 Isf II, were subcloned between sites BamHI and SmaI of vector pGEX-3X (Pharmacia) as BamHI ± ClaI (blunt-ended) and BamHI ± SmaI fragments, respectively. The C-terminal truncated mutants of hSos1 Isf I (CMRI, residues 1021 ± 1130) and hSos1 Isf II (CMRII, residues 1021 ± 1045) were PCRampli®ed using as primers oligonucleotides corresponding to positions 3061 ± 3390 of hSos1-Isf I and 3061 ± 3435 of hSos1-Isf II and providing restriction sites EcoRI and XhoI at the 5' and 3' ends, respectively. The sequences of the oligonucleotides utilized will be made available upon request. The ampli®ed products were then subcloned into pGEX-4T-1 (Pharmacia). The GST-CMR I and CMR II mutants in residues 1025 and 1028 (both CMR), and 1127, 1130 (only CMR II) were generated using speci®c primers in which proline was substituted for alanine, using the quickchange site-directed mutagenesis Kit (Stratagene). The sequence of all PCR-generated constructs was veri®ed by direct sequencing using Sequenase T7 (Amersham Corp.). The epitopetagged hSos1 Isf I (pCEFL-KZ-HA-hSos1 Isf I) and hSos1 Isf II (pCEFL-KZ-HA-hSos1 Isf II) were generated by inserting the full-length coding region of hSos1 (isoform I and II respectively) into the pCEFL-KZ-HA expression vector. To obtain the truncated mutants hSos1 CMR I and hSos1 CMR II, the 3'-region of hSos1 Isf I (position 3200 ± 3390) and the 3'-region of hSos1 Isf II (positions 3200 ± 3435) were PCR-ampli®ed providing restriction sites BamHI at 5' end and SacI and NotI at 3' end. The sequences of the oligonucleotides utilized will be made available upon request. The ampli®ed products were subcloned between sites BamHI and SacI of plasmids pSP72-hSos1 Isf I and pGEM3-hSos1 Isf II respectively. The epitope-tagged truncated mutants hSos1 CMRI (pCEFL-KZ-HA-hSos1 CMRI) and hSos1-CMRII (pCEFL-KZ-HA-hSos1 CMRII) were generated by inserting the coding region of the above hSos1 truncated mutants into the pCEFL-KZ-HA expression vector. Similarly, the plasmid pCEFL-KZ-HA-NDP (coding the Nterminal half of hSos1) was obtained by subcloning the 5'-region of hSos1 (positions 1 ± 1790) in the above pCEFL-KZ-HA vector. The double mutant hSos1 Isf II AA (pCEFL-KZ-HA-hSos1 Isf II AA) was obtained by subcloning between the two BglII sites of HA-hSos1 Isf II a PCR product generated by using speci®c primers of hSos1 Isf II in which reverse oligonucleotide the prolines 1127 and 1130 were substituted for alanines (like that CMRII AA). The plasmids pCEFL-KZ-AU5-H-RAS wt, pCEFL-KZ-AU5-H-RAS Val 12, pGal4-Luc and pcDNAIII-Gal4-Elk-1 were the kind gift of SJ Gutkind (Zohar et al., 1998) .
Bacterial expression of GST fusion proteins
The plasmid pGEX-RBD containing the Raf Ras-binding domain (amino acids 1 ± 149) fused to glutathione Stransferase (GST) was kindly provided by SJ Taylor and D Shalloway (Taylor and Shalloway, 1996) . A bacterial culture of Escherichia coli BL21 (DE3) harboring that plasmid, and growing in 500 ml of Luria-Bertani (LB) medium, was induced at an optical density at 600 nm of 0.5 for 3 h at 378 with 1 mM isopropyl-1-thio-b-D-galactopyranoside (IPTG, Calbiochem). The cells were collected by centrifugation at 3000 g for 30 min and the GST-RBD puri®cation was by following the previously described method (Taylor and Shalloway, 1996) . Similarly, the BL21(DE3) strain of Escherichia coli was also transformed with the vector pGEX-4T-1 encoding the fusion protein GST-PRI or GST-PRII, -CMRI or GST-CMRII. The transformed bacteria were grown in 500 ml of LB medium until the optical density at 600 nm was 0.5 at which time IPTG (1 mM) was added for 3 h at 378C. The cells were collected by centrifugation at 3000 g for 30 min and the protocol of protein puri®cation was as previously published (Rojas et al., 1996) .
Transfections
Transient transfections in Cos 1 and 293T cells were performed with the Lipofectamine reagent (Life Technologies, Inc.). Cos 1 cells to be serum starved received DMEM containing 0.5% fetal bovine serum 24 h after transfection and were then incubated for another 24 h. All assays were done 48 h after transfection. NIH3T3 cells were transfected (transient or stable) by the calcium phosphate precipitation technique. Morphologically transformed foci were scored after 2 ± 3 weeks in culture (Rojas et al., 1996) . Transfected cells were also selected in medium supplemented, as appropriate, with Geneticin 750 mg/ml (Life Technologies, Inc.).
Grb2 binding assays
Cell extracts from human T-24 and M426 cell lines were prepared by lysis in Nonidet P-40 buer (Cussac et al., 1994; Li et al., 1993b) . The lysates were cleared twice by centrifugation at 12 000 g for 15 min to obtain the nucleus free supernatants. The GST, GST-CMRI, GST-CMRII, GST-PRI and GST-PRII proteins, 10 mg, coupled to glutathione-sepharose beads were added to 1 mg of cell extracts and incubated for 120 min at 48C following the previous described methodology (Rojas et al., 1996) . The pull-down proteins were resolved by SDS-polyacrylamide gel electrophoresis (PAGE), transferred to nitrocellulose membranes (Schliehcer & Schuell) and probed with monoclonal anti-Grb2 (Transduction Laboratories) or with rabbit anti-GST polyclonal serum. Immunocomplexes were visualized by enhanced chemiluminescence detection (ECL, Amersham Corp.) using goat anti-mouse or goat anti-rabbit IgGs coupled to horseradish peroxidase as secondary antibody (Amersham Corp.).
Raf Ras-binding domain pull-down
Transfected cells, some stimulated for 10 min with Epidermal Growth Factor (EGF, Calbiochem), were lysed in cold lysis buer containing 25 mM HEPES pH 7.5, 1% Triton X-100, 150 mM NaCl, 10 mM MgCl 2 , 1 mM sodium orthovanadate (Na 3 VO 4 ), 25 mM NaF, 1 mM phenylmethylsulfonyl¯uoride (PMSF), 10 mg/ml of leupeptin, aprotinin, pepstatin A and trypsin inhibitor. Nucleus-free supernatants were incubated with GST-RBD on glutathione-sepharose beads at 48C for 1 h. The beads were then collected by centrifugation and washed three times with ice-cold PBS, 0.1% Triton X-100, 10 mM MgCl 2 . Ras proteins were separated by SDS ± PAGE and visualized by immunoblotting and ECL (Amersham) on nitrocellulose ®lters (Schleicher & Schuell) with anti-AU5 (Berkeley Antibody Company) or pan-Ras monoclonal antibodies (Transduction Laboratories).
Immunoprecipitation and antibodies
Transfected cells, some stimulated as described, were lysed in cold lysis buer containing 50 mM HEPES pH 7.5, 150 mM NaCl, 5 mM EDTA, 5 mM EGTA, 1% Triton X-100, 10% glycerol with protease and phosphatase inhibitors (1 mM PMSF, 10 mg/ml of leupeptin, aprotinin, pepstatin A and trypsin inhibitor, 10 mM benzamidine, 50 mM NaF and 2 mM sodium orthovanadate). Nucleus free supernatants were incubated with the appropriate antibody at 48C for 2 h. Protein G-Sepharose Plus (Pharmacia) was then added, and the incubation was carried out for an additional 1 h. Immune complexes were collected by centrifugation, washed ®ve times with lysis buer before being resolved by SDS ± PAGE, and visualized by immunoblotting and ECL. Grb2 polyclonal antibody was from Santa Cruz Biotechnology and anti-HA monoclonal antibody was from Berkeley Antibody Company.
Yeast two-hybrid system binding assays PCR derived fragments encoding for the appropriate CMRI, CMRII and PRII coding regions were subcloned into plasmid pEG202, expressing the LexA DNA binding domain. The full-length coding sequence for Grb2 was subcloned into plasmid pJG45, encoding the B42 activation domain. Saccharomyces cerevisiae EGY48 strain (MATa, his3, trp1, leu2 : : pLEU2-LexAop6) was used as a host. Cotransformation of two hybrid vectors into yeast were performed as described (Rojas et al., 1996 (Rojas et al., , 1999 . Protein ± protein interaction in the two-hybrid system was monitored on plates by Lac Z assay in the presence of 5-bromo-4-chloro-3-indoyl-b-D-galactopyranoside (X-Gal, Boehringer Mannheim) and by growing on medium without leucine. All these assays were comparatively performed in galactoseranose (induction of Grb2-B42 expression) and glucose (repression of Grb2-B42 expression) conditions (Mendelsohn and Brent, 1994) . EGY48 strain and plasmids pEG202 and pJG45 were the kind gift of R Brent (Mendelsohn and Brent, 1994) .
Reporter gene analysis
NIH3T3 cells were transfected with 0.6 mg of hSos1 or Ras constructs, together with 16 ng of pcDNAIII-Gal4-Elk-1, 0.1 mg of pRL-TK (a plasmid expressing the enzyme Renilla luciferase) and 0.3 mg of the reporter plasmid (pGal4-Luc), adjusting the total amount of plasmid DNA with empty vector. After overnight incubation, the cells were washed and kept for 24 h in DMEM supplemented with 0.5% calf serum. Cells were then lysed with passive lysis buer (Promega). Photinus and Renilla luciferase presents in the nucleus free supernatants were assayed with the Dual-Luciferase Reporter Assay System (Promega), and light emission was quantitated with a Monolight 2010 luminometer as speci®ed by the manufacturer (Analytical Luminescence Laboratory). The Renilla luciferase activity present in each sample was used to normalize Photinus luciferase activity for transfection eciency.
